Sort
15,842 grants matching “pancreatic cancer”
Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer
$314,031Kenneth P Olive · Columbia University Health Sciences · R01 · FY2013 · CA
Fatty Acid Transport in Eukaryotes
$314,030Paul N. Black · University Of Nebraska Lincoln · R01 · FY2009 · GM
Project 3: The Functional Contribution of Tumor Immunity in PDAC
$314,011Raghu Kalluri · University Of Tx Md Anderson Can Ctr · P01 · FY2019 · CA
Role of PALB2 in the DNA damage response and breast cancer suppression
$313,989Bing Xia · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2011 · CA
Stat3 Signaling in Pancreas Cancer
$313,989Nipun B. Merchant · Vanderbilt University · R01 · FY2014 · CA
Tumor Suppression by Telomere Dysfunction Induced Senescence
$313,989Utz Herbig · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2012 · CA
Role of PALB2 in the DNA damage response and breast cancer suppression
$313,989Bing Xia · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2012 · CA
Tumor Suppression by Telomere Dysfunction Induced Senescence
$313,989Utz Herbig · Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2011 · CA
Kras-Induced Cellular Plasticity in Pancreatic Cancer
$313,971Stephen F Konieczny · Purdue University · R01 · FY2010 · CA
Phosphatidylinositol 3-kinase and prevention of pancreatic cancer
$313,959Richard Z Lin · State University New York Stony Brook · R01 · FY2012 · CA
Phosphatidylinositol 3-kinase and prevention of pancreatic cancer
$313,959Richard Z Lin · State University New York Stony Brook · R01 · FY2011 · CA
Fatty Acid Transport in Eukaryotes
$313,848Paul N. Black · University Of Nebraska Lincoln · R01 · FY2010 · GM
Targeting transient receptor potential channels to suppress proviral mitochondrial fission and mitophagy in order to mitigate CVB pancreatitis
$313,814Jon Sin · University Of Alabama In Tuscaloosa · R01 · FY2023 · DK
T-32 NIH Postdoctoral Training Program in Nanotechnology for Cancer Medicine NTCM
$313,802Denis Wirtz · Johns Hopkins University · T32 · FY2010 · CA
INHIBITION OF PANCREATIC CANCER CELL PROLIFERATION BY LRH-1 INHIBITORS
$313,690Regents Of The University Of California, San Francisco, The · · FY2012 · Department of the Army
Targeting tumor-stromal interaction for pancreatic cancer therapy
$313,585Ajay Pratap Singh · University Of South Alabama · R01 · FY2015 · CA
Digestive Diseases Training Program
$313,572David C Whitcomb · University Of Pittsburgh At Pittsburgh · T32 · FY2010 · DK
Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm
$313,533Richard G Vile · Mayo Clinic Rochester · R01 · FY2009 · CA
Pharmacogenomics and Mechanisms of Cytidine Analogues
$313,533Liewei Wang · Mayo Clinic Rochester · R01 · FY2009 · CA
Pharmacogenomics and Mechanisms of Cytidine Analogues
$313,533Liewei Wang · Mayo Clinic Rochester · R01 · FY2010 · CA
Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm
$313,533Richard G Vile · Mayo Clinic Rochester · R01 · FY2008 · CA
Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm
$313,533Richard G Vile · Mayo Clinic Rochester · R01 · FY2010 · CA
Development of a gold nanoparticles based targeted delivery system
$313,533Priyabrata Mukherjee · Mayo Clinic Rochester · R01 · FY2010 · CA
Serum glycoprotein markers of cancer using an ion mobility/mass spec approach
$313,429David M. Lubman · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Develop and High-Throughput Screening of Targeted Anticancer Nanomedicines
$313,331Valery A Petrenko · Northeastern University · U54 · FY2012 · CA